Myeloid progenitors derived from bone marrow (green) injected into the eyes of mice differentiate into cells with characteristics of microglia. These cells assume a perivascular localization in the retina (vessels labeled in red) and meditate vascular repair. These findings suggest a new approach, using cell therapy, to the treatment of prevalent eye diseases such as diabetic retinopathy and retinopathy of prematurity.